Evidence map›Paper›PMID 35891334›Full record

ArticleViruses2022

Applying Modified VP53A Recombinant Protein as an Anti-White Spot Syndrome Virus Biological Agent in

Jeff Chia-Kai Hsu, Huai-Ting Huang, Han-Jia Lin, Hsin-Yiu Chou, Po-Yu Huang, Anuphap Prachumwat, Li-Li Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jeff Chia-Kai HsuInstitute of Marine Biology, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID 0000-0003-1448-5232
Huai-Ting HuangDepartment of Aquaculture, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID 0000-0002-6563-267X
Han-Jia LinDepartment of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID 0000-0002-4929-6573
Hsin-Yiu ChouDepartment of Aquaculture, National Taiwan Ocean University, Keelung 20224, Taiwan.
Po-Yu HuangDepartment of Life Science, National Taitung University, Taitung 95092, Taiwan.
Anuphap PrachumwatAquatic Animal Health Research Team, Integrative Aquaculture Biotechnology Research Group, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand.ORCID 0000-0002-2009-5524
Li-Li ChenInstitute of Marine Biology, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID 0000-0002-9593-8004
National Taiwan Ocean University · TWNational Science and Technology Development Agency · THNational Taitung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shrimp farming is an important economic activity. However, due to the spread of pathogens, shrimp aquaculture is becoming increasingly difficult. Many studies have confirmed that white spot syndrome virus (WSSV) recombinant proteins can inhibit viral infection. Among them, VP53 recombinant protein has been found to reduce mortality upon WSSV challenge. This study was conducted in Kaohsiung, Taiwan and reports the first field feeding trial to demonstrate that WSSV recombinant proteins can improve shrimp survival rates at a farming scale. Prior to the feeding trial, the shrimp were confirmed to be slightly infected with WSSV,

Indexed as

PenaeidaeWhite spot syndrome virus 1AnimalsAquacultureBiological FactorsRecombinant ProteinsBiological FactorsRecombinant Proteinsimmune geneintestinal microbiotarecombinant proteinshrimp

Identifiers

PMID35891334
PMCPMC9324474
OpenAlexW4283318062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.